NRAS is one of the three canonical human RAS small GTPases (with HRAS and KRAS). It is a peripheral membrane protein anchored to the cytoplasmic face of cellular membranes through C-terminal lipidation (farnesylation at Cys-186 and palmitoylation at Cys-181) and functions as a binary molecular switch that binds GDP/GTP and possesses intrinsic GTPase activity. Cycling between an inactive GDP-bound and an active GTP-bound state under the control of guanine nucleotide exchange factors (GEFs such as SOS1 and RasGRP) and GTPase-activating proteins (GAPs), active GTP-bound NRAS transduces signals from receptor tyrosine kinases to downstream effectors, principally the RAF-MEK-ERK (MAPK) cascade and PI3K, thereby promoting cell proliferation, survival and differentiation. NRAS undergoes a constitutive de/re-palmitoylation acylation cycle that drives rapid shuttling between the plasma membrane and the Golgi apparatus, providing spatial control of signaling. Activating somatic and germline mutations at codons 12, 13 and 61 impair GTP hydrolysis and lock NRAS in its active state, a major oncogenic and developmental-disorder mechanism.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0005886
plasma membrane
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: NRAS is a lipid-anchored peripheral membrane protein active on the cytoplasmic face of the plasma membrane, where GTP-bound NRAS engages RAF and other effectors. This is a core, well-supported phylogenetic localization for the RAS family.
Reason: Plasma membrane is the principal site of action for NRAS signaling and is strongly supported across orthologs (IBA) and by direct experimental evidence in human cells.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
PMID:26701913
ABHD17 catalytic activity is required for N-Ras depalmitoylation and re-localization to internal cellular membranes.
|
|
GO:0007265
Ras protein signal transduction
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Ras protein signal transduction is the defining biological process of NRAS, which acts as a GTP/GDP-regulated switch transducing receptor tyrosine kinase input to downstream effectors (RAF-MEK-ERK, PI3K). Conserved across the RAS family.
Reason: This is the central core biological process for NRAS, supported phylogenetically (IBA) and by direct experimental evidence (see the IDA row for PMID:30712867).
Supporting Evidence:
PMID:30712867
STK19 phosphorylates NRAS to enhance its binding to its downstream effectors and promotes oncogenic NRAS-mediated melanocyte malignant transformation.
|
|
GO:0008284
positive regulation of cell population proliferation
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: Active NRAS signaling through the MAPK and PI3K pathways promotes cell proliferation, and oncogenic NRAS mutations drive uncontrolled proliferation. This is a genuine but downstream consequence of NRAS signal transduction.
Reason: Promotion of proliferation is a real, conserved role of RAS GTPases but is a downstream physiological output of the core GTPase/signal-transduction function rather than the molecular activity itself. Retained as a non-core process.
Supporting Evidence:
PMID:30712867
Activating mutations in NRAS account for 20%-30% of melanoma.
|
|
GO:0003924
GTPase activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: NRAS hydrolyzes GTP to GDP (EC 3.6.5.2), the catalytic activity underlying its switch behavior. Intrinsic GTPase activity is the canonical molecular function of all RAS-family proteins and is impaired by oncogenic codon-12/13/61 mutations.
Reason: GTPase activity is a core molecular function, supported phylogenetically (IBA) and directly (PMID:30712867; UniProt FUNCTION/CATALYTIC ACTIVITY).
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
Ras proteins bind GDP/GTP and possess intrinsic GTPase activity.
file:human/NRAS/NRAS-uniprot.txt
Reaction=GTP + H2O = GDP + phosphate + H(+); ... EC=3.6.5.2
|
|
GO:0000139
Golgi membrane
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: NRAS localizes to the Golgi apparatus membrane as part of its de/re-palmitoylation acylation cycle, shuttling between the plasma membrane and Golgi. UniProt subcellular location vocabulary maps to this term.
Reason: Golgi membrane is an experimentally supported core localization for NRAS (see EXP rows PMID:15705808, PMID:26701913); the UniProt SubCell IEA mapping is consistent.
Supporting Evidence:
PMID:15705808
driving their rapid exchange between the plasma membrane (PM) and the Golgi apparatus.
|
|
GO:0000165
MAPK cascade
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: NRAS is an upstream activator of the RAF-MEK-ERK MAPK cascade; GTP-bound NRAS recruits and activates RAF kinases, initiating the cascade.
Reason: MAPK cascade is a core biological process for NRAS, also supported by Reactome TAS (RAF/MAP kinase cascade) and by direct effector-binding evidence.
Supporting Evidence:
PMID:18641128
eNOS selectively activates N-Ras but not K-Ras on the Golgi complex of T cells engaged with APC.
|
|
GO:0003924
GTPase activity
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: InterPro small-GTPase signature (IPR001806) maps NRAS to GTPase activity, its canonical catalytic molecular function.
Reason: Correct InterPro2GO mapping consistent with the IBA/IDA/ISS GTPase activity rows.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
Ras proteins bind GDP/GTP and possess intrinsic GTPase activity.
|
|
GO:0003925
G protein activity
|
IEA
GO_REF:0000003 |
KEEP AS NON CORE |
Summary: G protein activity is the EC-mapped (EC 3.6.5.2) molecular function for the small monomeric GTPase enzyme class. For NRAS this is the same underlying GTP-hydrolyzing activity captured more specifically as GTPase activity (GO:0003924).
Reason: The term is not wrong, but GTPase activity (GO:0003924) is the more standard and specific molecular-function descriptor for RAS proteins and is already present. Retained as a non-core duplicate of the core enzymatic activity rather than the preferred term.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
Reaction=GTP + H2O = GDP + phosphate + H(+); ... EC=3.6.5.2
|
|
GO:0005525
GTP binding
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: NRAS binds GTP (and GDP) via its conserved P-loop and G-box motifs; nucleotide binding is the basis of its switch function. InterPro small-GTPase signatures map here.
Reason: GTP binding is a core molecular function directly supported by the crystal structure (GDP-bound) and the conserved GTP-binding sites in the UniProt record.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
Ras proteins bind GDP/GTP and possess intrinsic GTPase activity.
|
|
GO:0005886
plasma membrane
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: Plasma membrane localization of NRAS via the UniProt SubCell vocabulary mapping, consistent with its lipid-anchored peripheral membrane attachment.
Reason: Core localization, redundant with the IBA/IDA/EXP plasma membrane rows.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0007165
signal transduction
|
IEA
GO_REF:0000002 |
KEEP AS NON CORE |
Summary: Generic signal transduction is correct for NRAS but is a broad parent of the more specific and better-supported Ras protein signal transduction (GO:0007265) and MAPK cascade (GO:0000165) annotations already present.
Reason: Not wrong, but less informative than the specific Ras-signal-transduction terms. Retained as a non-core broad classifier.
Supporting Evidence:
PMID:30712867
STK19 phosphorylates NRAS to enhance its binding to its downstream effectors and promotes oncogenic NRAS-mediated melanocyte malignant transformation.
|
|
GO:0016020
membrane
|
IEA
GO_REF:0000002 |
MARK AS OVER ANNOTATED |
Summary: Generic membrane localization from the InterPro small-GTPase mapping. NRAS is a membrane-anchored protein, but the specific plasma-membrane and Golgi-membrane terms are far more informative.
Reason: The bare membrane term loses the diagnostic plasma-membrane/Golgi-membrane specificity that is well established for NRAS.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005515
protein binding
|
IPI
PMID:18641128 Endothelial nitric oxide synthase regulates N-Ras activation... |
MARK AS OVER ANNOTATED |
Summary: IntAct binary interaction (NRAS with RAF1/CRAF, P04049). This reflects NRAS binding its downstream RAF effector, consistent with its role activating the MAPK cascade, but it is captured only as the uninformative generic protein binding term.
Reason: Bare protein binding (GO:0005515) is uninformative per curation guidelines. The biologically meaningful RAS-RAF effector engagement is already represented by the Ras protein signal transduction and MAPK cascade process annotations; the underlying study concerns eNOS-regulated N-Ras activation on the Golgi.
Supporting Evidence:
PMID:18641128
eNOS selectively activates N-Ras but not K-Ras on the Golgi complex of T cells engaged with APC.
|
|
GO:0005515
protein binding
|
IPI
PMID:20080631 Ras membrane orientation and nanodomain localization generat... |
MARK AS OVER ANNOTATED |
Summary: IntAct binary interaction (NRAS with RAF1/CRAF, P04049) from a study of Ras membrane orientation and nanodomain localization. Captured as the generic protein binding term.
Reason: Bare protein binding (GO:0005515) is uninformative. The RAS-RAF effector interaction and membrane-nanodomain context are already represented by the signal-transduction and plasma-membrane annotations.
Supporting Evidence:
PMID:20080631
Ras membrane orientation and nanodomain localization generate isoform diversity.
|
|
GO:0005515
protein binding
|
IPI
PMID:21478863 ERK and PDE4 cooperate to induce RAF isoform switching in me... |
MARK AS OVER ANNOTATED |
Summary: IntAct binary interactions (NRAS with RAF1 P04049, BRAF P15056, Braf P28028, Raf1 Q99N57) from a study of ERK/PDE4-driven RAF isoform switching in melanoma. Reflects NRAS binding RAF effectors, captured only as generic protein binding.
Reason: Bare protein binding (GO:0005515) is uninformative. The RAS-RAF effector engagement is already represented by the Ras protein signal transduction and MAPK cascade processes.
Supporting Evidence:
PMID:21478863
ERK and PDE4 cooperate to induce RAF isoform switching in melanoma.
|
|
GO:0005515
protein binding
|
IPI
PMID:28514442 Architecture of the human interactome defines protein commun... |
MARK AS OVER ANNOTATED |
Summary: IntAct interaction (NRAS with RIN1, Q13671) from a high-throughput interactome map defining protein communities and disease networks. Captured as generic protein binding.
Reason: Bare protein binding (GO:0005515) from a large-scale interactome screen is uninformative as a molecular-function annotation; it does not define a specific NRAS activity beyond interactions already implied by its effector/regulator network.
Supporting Evidence:
PMID:28514442
Architecture of the human interactome defines protein communities and disease networks.
|
|
GO:0005515
protein binding
|
IPI
PMID:30194290 Interrogating the protein interactomes of RAS isoforms ident... |
MARK AS OVER ANNOTATED |
Summary: IntAct interactions (NRAS with RAF1 P04049 and BRAF P15056) from a study interrogating RAS-isoform interactomes (identified PIP5K1A as a KRAS-specific vulnerability). Reflects NRAS-RAF effector binding, captured as generic protein binding.
Reason: Bare protein binding (GO:0005515) is uninformative; the RAS-RAF effector interaction is already represented by the signal-transduction/MAPK annotations.
Supporting Evidence:
PMID:30194290
Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability.
|
|
GO:0005515
protein binding
|
IPI
PMID:31209342 GGTase3 is a newly identified geranylgeranyltransferase targ... |
MARK AS OVER ANNOTATED |
Summary: IntAct interaction (NRAS with RABGGTB/GGTase component P49354) from the study identifying GGTase3, a geranylgeranyltransferase. Captured as generic protein binding.
Reason: Bare protein binding (GO:0005515) is uninformative. NRAS lipidation/prenylation is relevant to its membrane targeting, but this interaction is not by itself an informative molecular-function annotation.
Supporting Evidence:
PMID:31209342
GGTase3 is a newly identified geranylgeranyltransferase targeting a ubiquitin ligase.
|
|
GO:0005515
protein binding
|
IPI
PMID:31980649 Extensive rewiring of the EGFR network in colorectal cancer ... |
MARK AS OVER ANNOTATED |
Summary: IntAct interaction (NRAS with RAF1, P04049) from a study of EGFR-network rewiring in KRAS(G13D) colorectal cancer cells. Captured as generic protein binding.
Reason: Bare protein binding (GO:0005515) is uninformative; RAS-RAF effector engagement is already represented by the signal-transduction/MAPK annotations.
Supporting Evidence:
PMID:31980649
Extensive rewiring of the EGFR network in colorectal cancer cells expressing transforming levels of KRAS(G13D).
|
|
GO:0005515
protein binding
|
IPI
PMID:32296183 A reference map of the human binary protein interactome. |
MARK AS OVER ANNOTATED |
Summary: IntAct interactions (NRAS with RAF1 P04049, RAP1GDS1/SmgGDS P52306-5, RIN1 Q13671, RGL3 Q3MIN7, ARAF Q96II5) from a reference map of the human binary protein interactome. Includes genuine effectors/regulators but captured only as generic protein binding.
Reason: Bare protein binding (GO:0005515) from a large binary interactome map is uninformative as a molecular function; the relevant effector/GEF interactions are already represented by the Ras signal-transduction annotations.
Supporting Evidence:
PMID:32296183
A reference map of the human binary protein interactome.
|
|
GO:0005515
protein binding
|
IPI
PMID:32707033 Kinase Interaction Network Expands Functional and Disease Ro... |
MARK AS OVER ANNOTATED |
Summary: IntAct interaction (NRAS with BRAF, P15056) from a kinase interaction network study. Reflects NRAS-RAF effector binding, captured as generic protein binding.
Reason: Bare protein binding (GO:0005515) is uninformative; the RAS-RAF effector interaction is already represented by the signal-transduction/MAPK annotations.
Supporting Evidence:
PMID:32707033
Kinase Interaction Network Expands Functional and Disease Roles of Human Kinases.
|
|
GO:0005515
protein binding
|
IPI
PMID:32814053 Interactome Mapping Provides a Network of Neurodegenerative ... |
MARK AS OVER ANNOTATED |
Summary: IntAct interaction (NRAS with PIK3R1 isoform P27986-2) from an interactome map of neurodegenerative disease proteins. PIK3R1 is the PI3K regulatory subunit, an NRAS effector arm, but captured as generic protein binding.
Reason: Bare protein binding (GO:0005515) is uninformative; the PI3K effector engagement is already implied by the Ras signal-transduction annotations.
Supporting Evidence:
PMID:32814053
Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins and Uncovers Widespread Protein Aggregation in Affected Brains.
|
|
GO:0005515
protein binding
|
IPI
PMID:33961781 Dual proteome-scale networks reveal cell-specific remodeling... |
MARK AS OVER ANNOTATED |
Summary: IntAct interaction (NRAS with RIN1, Q13671) from dual proteome-scale interactome networks. Captured as generic protein binding.
Reason: Bare protein binding (GO:0005515) from a large-scale interactome screen is uninformative as a molecular-function annotation.
Supporting Evidence:
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
|
|
GO:0005515
protein binding
|
IPI
PMID:34591642 A protein network map of head and neck cancer reveals PIK3CA... |
MARK AS OVER ANNOTATED |
Summary: IntAct interactions (NRAS with RAF1 P04049, BRAF P15056, RIN1 Q13671) from a protein network map of head and neck cancer. Captured as generic protein binding.
Reason: Bare protein binding (GO:0005515) is uninformative; the RAS-RAF/effector interactions are already represented by the signal-transduction/MAPK annotations.
Supporting Evidence:
PMID:34591642
A protein network map of head and neck cancer reveals PIK3CA mutant drug sensitivity.
|
|
GO:0005515
protein binding
|
IPI
PMID:35512704 Systematic discovery of mutation-directed neo-protein-protei... |
MARK AS OVER ANNOTATED |
Summary: IntAct interaction (NRAS with BRAF, P15056) from a study of mutation-directed neo-protein-protein interactions in cancer. Captured as generic protein binding.
Reason: Bare protein binding (GO:0005515) is uninformative; the RAS-RAF effector interaction is already represented by the signal-transduction/MAPK annotations.
Supporting Evidence:
PMID:35512704
Systematic discovery of mutation-directed neo-protein-protein interactions in cancer.
|
|
GO:0005515
protein binding
|
IPI
PMID:35839996 A Proteomic Approach Identifies Isoform-Specific and Nucleot... |
MARK AS OVER ANNOTATED |
Summary: IntAct interactions (NRAS with RAF1 P04049, RABGGTB P49354, and Q96JH8) from a proteomic study of isoform-specific and nucleotide-dependent RAS interactions. Captured as generic protein binding.
Reason: Bare protein binding (GO:0005515) is uninformative; nucleotide-dependent effector interactions are already represented by the Ras signal-transduction annotations.
Supporting Evidence:
PMID:35839996
A Proteomic Approach Identifies Isoform-Specific and Nucleotide-Dependent RAS Interactions.
|
|
GO:0005515
protein binding
|
IPI
PMID:40205054 Multimodal cell maps as a foundation for structural and func... |
MARK AS OVER ANNOTATED |
Summary: IntAct interaction (NRAS with RIN1, Q13671) from a multimodal cell-map study. Captured as generic protein binding.
Reason: Bare protein binding (GO:0005515) from a large-scale mapping study is uninformative as a molecular-function annotation.
Supporting Evidence:
PMID:40205054
Multimodal cell maps as a foundation for structural and functional genomics.
|
|
GO:0000165
MAPK cascade
|
TAS
Reactome:R-HSA-5673001 |
ACCEPT |
Summary: Reactome places NRAS in the RAF/MAP kinase cascade, consistent with its core role as an upstream activator of RAF-MEK-ERK signaling.
Reason: Core biological process, concordant with the IEA MAPK cascade row and effector-binding evidence.
Supporting Evidence:
Reactome:R-HSA-5673001
RAF/MAP kinase cascade.
|
|
GO:0046579
positive regulation of Ras protein signal transduction
|
NAS
PMID:35831509 Structure-function analysis of the SHOC2-MRAS-PP1C holophosp... |
KEEP AS NON CORE |
Summary: Active GTP-bound NRAS binds the SHOC2-PP1C holophosphatase complex, which dephosphorylates inhibitory sites on RAF to promote RAF activation, positively regulating Ras/MAPK signaling. This NAS annotation derives from the ComplexPortal SHOC2-NRAS-PPP1CA complex.
Reason: This represents NRAS participation in a positive-feedback/effector-activation complex rather than its core intrinsic GTPase switch activity. It is a valid, more specialized process, retained as non-core.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
Interacts (active GTP-bound form) with both SHOC2 and PP1c (all isoforms) to form a tertiary complex; SHOC2 and PP1c preferably bind M-Ras/MRAS, but they also bind K-Ras/KRAS, N-Ras/NRAS and H-Ras/HRAS
|
|
GO:0005886
plasma membrane
|
IDA
GO_REF:0000052 |
ACCEPT |
Summary: Immunofluorescence (Human Protein Atlas) localizes NRAS to the plasma membrane, consistent with its lipid-anchored membrane attachment.
Reason: Direct (IDA) support for the core plasma-membrane localization.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0000139
Golgi membrane
|
EXP
PMID:15705808 An acylation cycle regulates localization and activity of pa... |
ACCEPT |
Summary: NRAS is experimentally localized to the Golgi apparatus membrane, where the de/re-palmitoylation acylation cycle traps farnesylated Ras before redirection to the plasma membrane.
Reason: Direct experimental support for core Golgi-membrane localization as part of the PM-Golgi shuttling cycle.
Supporting Evidence:
PMID:15705808
Depalmitoylation redistributes farnesylated Ras in all membranes, followed by repalmitoylation and trapping of Ras at the Golgi, from where it is redirected to the PM via the secretory pathway.
|
|
GO:0000139
Golgi membrane
|
EXP
PMID:26701913 ABHD17 proteins are novel protein depalmitoylases that regul... |
ACCEPT |
Summary: NRAS localizes to Golgi/internal membranes, with ABHD17 depalmitoylase activity controlling its palmitate turnover and relocalization between plasma membrane and internal membranes.
Reason: Direct experimental support for core Golgi-membrane localization in the context of palmitoylation-dependent trafficking.
Supporting Evidence:
PMID:26701913
ABHD17 catalytic activity is required for N-Ras depalmitoylation and re-localization to internal cellular membranes.
|
|
GO:0003924
GTPase activity
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: GTPase activity transferred by sequence similarity from KRAS (P01116). NRAS shares the canonical RAS catalytic machinery and intrinsic GTPase activity.
Reason: Correct similarity-based assignment of the core GTPase molecular function, fully concordant with the IBA/IDA evidence.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
Ras proteins bind GDP/GTP and possess intrinsic GTPase activity.
|
|
GO:0005886
plasma membrane
|
EXP
PMID:15705808 An acylation cycle regulates localization and activity of pa... |
ACCEPT |
Summary: NRAS is experimentally localized to the plasma membrane, the principal signaling site, as part of the PM-Golgi acylation shuttling cycle.
Reason: Direct experimental support for the core plasma-membrane localization.
Supporting Evidence:
PMID:15705808
driving their rapid exchange between the plasma membrane (PM) and the Golgi apparatus.
|
|
GO:0005886
plasma membrane
|
EXP
PMID:26701913 ABHD17 proteins are novel protein depalmitoylases that regul... |
ACCEPT |
Summary: NRAS plasma-membrane localization is palmitoylation-dependent; ABHD17 depalmitoylase activity drives N-Ras relocalization from the plasma membrane to internal membranes, and loss of palmitoylation (Cys181Ser) abolishes plasma-membrane localization.
Reason: Direct experimental support for the core plasma-membrane localization.
Supporting Evidence:
PMID:26701913
ABHD17 catalytic activity is required for N-Ras depalmitoylation and re-localization to internal cellular membranes.
|
|
GO:0003924
GTPase activity
|
TAS
Reactome:R-HSA-9649736 |
ACCEPT |
Summary: Reactome attributes GTPase activity to NRAS, its canonical catalytic molecular function.
Reason: Concordant with the core GTPase activity annotations (IBA/IDA/ISS/IEA).
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
Ras proteins bind GDP/GTP and possess intrinsic GTPase activity.
|
|
GO:0000139
Golgi membrane
|
TAS
Reactome:R-HSA-9647980 |
ACCEPT |
Summary: Reactome RAS-processing/localization events place NRAS at the Golgi apparatus membrane, a bona-fide localization in its PM-Golgi shuttling cycle.
Reason: Concordant with the experimentally supported core Golgi-membrane localization.
Supporting Evidence:
PMID:15705808
driving their rapid exchange between the plasma membrane (PM) and the Golgi apparatus.
|
|
GO:0000139
Golgi membrane
|
TAS
Reactome:R-HSA-9647982 |
ACCEPT |
Summary: Reactome RAS-processing/localization events place NRAS at the Golgi apparatus membrane, a bona-fide localization in its PM-Golgi shuttling cycle.
Reason: Concordant with the experimentally supported core Golgi-membrane localization.
Supporting Evidence:
PMID:15705808
driving their rapid exchange between the plasma membrane (PM) and the Golgi apparatus.
|
|
GO:0005789
endoplasmic reticulum membrane
|
TAS
Reactome:R-HSA-9647977 |
KEEP AS NON CORE |
Summary: Reactome RAS-processing events localize NRAS to the endoplasmic reticulum membrane, where post-translational CAAX processing (RCE1/ICMT) of newly farnesylated Ras occurs en route to the Golgi and plasma membrane.
Reason: ER membrane is a transient processing/transit site rather than the principal signaling location (plasma membrane/Golgi). Retained as a non-core localization supported only by Reactome pathway knowledge.
Supporting Evidence:
PMID:15705808
from where it is redirected to the PM via the secretory pathway.
|
|
GO:0005789
endoplasmic reticulum membrane
|
TAS
Reactome:R-HSA-9647978 |
KEEP AS NON CORE |
Summary: Reactome RAS-processing events localize NRAS to the endoplasmic reticulum membrane, where post-translational CAAX processing (RCE1/ICMT) of newly farnesylated Ras occurs en route to the Golgi and plasma membrane.
Reason: ER membrane is a transient processing/transit site rather than the principal signaling location (plasma membrane/Golgi). Retained as a non-core localization supported only by Reactome pathway knowledge.
Supporting Evidence:
PMID:15705808
from where it is redirected to the PM via the secretory pathway.
|
|
GO:0005789
endoplasmic reticulum membrane
|
TAS
Reactome:R-HSA-9647982 |
KEEP AS NON CORE |
Summary: Reactome RAS-processing events localize NRAS to the endoplasmic reticulum membrane, where post-translational CAAX processing (RCE1/ICMT) of newly farnesylated Ras occurs en route to the Golgi and plasma membrane.
Reason: ER membrane is a transient processing/transit site rather than the principal signaling location (plasma membrane/Golgi). Retained as a non-core localization supported only by Reactome pathway knowledge.
Supporting Evidence:
PMID:15705808
from where it is redirected to the PM via the secretory pathway.
|
|
GO:0005789
endoplasmic reticulum membrane
|
TAS
Reactome:R-HSA-9647999 |
KEEP AS NON CORE |
Summary: Reactome RAS-processing events localize NRAS to the endoplasmic reticulum membrane, where post-translational CAAX processing (RCE1/ICMT) of newly farnesylated Ras occurs en route to the Golgi and plasma membrane.
Reason: ER membrane is a transient processing/transit site rather than the principal signaling location (plasma membrane/Golgi). Retained as a non-core localization supported only by Reactome pathway knowledge.
Supporting Evidence:
PMID:15705808
from where it is redirected to the PM via the secretory pathway.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-1168636 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-1225951 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-1225957 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-1250383 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-1306972 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-1433471 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-170986 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-177938 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-177945 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-186834 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-210977 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-2179407 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-2424477 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-392054 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-5218845 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-5621573 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-5624486 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-5624492 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-5624494 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-5637806 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-5637808 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-5654392 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-5654402 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-5654413 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-5654426 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-5654600 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-5654618 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-5654647 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-5654663 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-5655241 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-5655277 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-5655326 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-5655347 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-5658231 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-5658435 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-5672950 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-5672965 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-5672966 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-5672969 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-5672972 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-5672973 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-5672978 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-5672980 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-5674018 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-5674022 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-5675417 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-5675431 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-5675433 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-6802837 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-8851827 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-8851877 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-8851899 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-8941613 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-8941618 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-8941623 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-8941628 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-8981353 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-8981355 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-9607304 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-9632906 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-9632918 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-9634418 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-9647980 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-9647994 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-9649733 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-9649735 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-9649736 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-9653108 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-9656209 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-9656211 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-9656212 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-9656213 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-9656214 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-9656215 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-9657599 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-9657603 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-9657606 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-9657608 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-9658253 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-9664991 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-9665009 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-9665404 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-9665408 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-9665700 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-9665707 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-9670436 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-9672163 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-9672170 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-9695853 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-9703441 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-9647978 |
KEEP AS NON CORE |
Summary: Reactome localizes newly synthesized, pre-processed (farnesylated but not yet membrane-anchored) NRAS to the cytosol during RAS processing.
Reason: Cytosolic localization applies transiently to nascent unprocessed NRAS; the mature, functionally active protein is membrane-anchored. Retained as a non-core processing-stage location.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-6802834 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-6802908 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-6802918 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-6802922 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-6802924 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-6802925 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-6802926 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-6802937 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-6802941 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-6802942 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-6802943 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-6803233 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-6803234 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-6803240 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-8936731 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-9651280 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0003924
GTPase activity
|
IDA
PMID:30712867 Pharmacological Targeting of STK19 Inhibits Oncogenic NRAS-D... |
ACCEPT |
Summary: Direct experimental study of NRAS function, including characterization of the oncogenic Q61R variant and STK19-mediated Ser-89 phosphorylation; UniProt cites this work (ECO:0000269|PubMed:30712867) for NRAS GDP/GTP binding and intrinsic GTPase activity.
Reason: Provides direct experimental (IDA) support for the core GTPase molecular function of NRAS.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
Ras proteins bind GDP/GTP and possess intrinsic GTPase activity. {ECO:0000269|PubMed:30712867}.
|
|
GO:0007265
Ras protein signal transduction
|
IDA
PMID:30712867 Pharmacological Targeting of STK19 Inhibits Oncogenic NRAS-D... |
ACCEPT |
Summary: NRAS transduces signals to downstream effectors; STK19 phosphorylates NRAS at Ser-89 to enhance effector binding and promote oncogenic NRAS-driven melanocyte transformation, providing direct evidence for NRAS signal transduction.
Reason: Direct experimental (IDA) support for the core Ras-protein-signal-transduction process.
Supporting Evidence:
PMID:30712867
STK19 phosphorylates NRAS to enhance its binding to its downstream effectors and promotes oncogenic NRAS-mediated melanocyte malignant transformation.
|
|
GO:0044877
protein-containing complex binding
|
IDA
PMID:23209302 KIF14 negatively regulates Rap1a-Radil signaling during brea... |
MARK AS OVER ANNOTATED |
Summary: This annotation derives from a study focused on KIF14 and Rap1a-Radil signaling in breast cancer; NRAS is not the subject of that work, and the protein-containing complex binding term is generic.
Reason: The cited paper does not characterize a specific NRAS molecular function; the generic complex-binding term adds little beyond NRAS's established effector/regulator interactions already captured by its signal-transduction annotations.
Supporting Evidence:
PMID:23209302
KIF14 negatively regulates Rap1a-Radil signaling during breast cancer progression.
|
|
GO:0001938
positive regulation of endothelial cell proliferation
|
IMP
PMID:23619365 MicroRNA-146a is a therapeutic target and biomarker for peri... |
KEEP AS NON CORE |
Summary: In endothelial cells, miR-146a downregulates NRAS and thereby attenuates angiogenesis, implying that NRAS normally supports endothelial cell proliferation and angiogenesis. This is a tissue-specific downstream output of NRAS/MAPK signaling.
Reason: The role in endothelial cell proliferation is a peripheral, cell-type-specific consequence of the core NRAS signaling function rather than its defining activity. Retained as a non-core process.
Supporting Evidence:
PMID:23619365
which attenuated angiogenesis through downregulation of NRAS.
|
|
GO:0070821
tertiary granule membrane
|
TAS
Reactome:R-HSA-6798747 |
MARK AS OVER ANNOTATED |
Summary: This Reactome annotation (neutrophil degranulation pathway) places NRAS at the tertiary granule membrane in neutrophils. It reflects pathway-level granule-proteome membership rather than a core functional localization.
Reason: Tertiary granule membrane is a cell-type-specific membrane compartment derived from a degranulation proteome pathway; it is far less informative than the established plasma membrane/Golgi localizations and does not represent the core site of NRAS signaling.
Supporting Evidence:
Reactome:R-HSA-6798747
Neutrophil degranulation.
|
|
GO:0016020
membrane
|
HDA
PMID:19946888 Defining the membrane proteome of NK cells. |
MARK AS OVER ANNOTATED |
Summary: NRAS was detected in a high-throughput NK-cell membrane proteome. Generic membrane localization is consistent with NRAS being a membrane-anchored protein but is much less informative than its specific plasma-membrane/Golgi-membrane localizations.
Reason: The bare membrane term from a proteomic dataset loses the diagnostic plasma-membrane/Golgi specificity already well established for NRAS.
Supporting Evidence:
PMID:19946888
Defining the membrane proteome of NK cells.
|
|
GO:0070062
extracellular exosome
|
HDA
PMID:20458337 MHC class II-associated proteins in B-cell exosomes and pote... |
MARK AS OVER ANNOTATED |
Summary: NRAS was detected in a proteomic survey of B-cell exosomes. This is a high-throughput co-purification rather than evidence of a functional exosomal role.
Reason: Exosomal detection of a membrane-anchored signaling GTPase likely reflects membrane co-isolation; it does not represent a core localization or function and over-annotates the established plasma-membrane/Golgi biology.
Supporting Evidence:
PMID:20458337
MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-6798747 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-6802914 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-6802915 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-6802916 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-6802919 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-6802921 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-6803230 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005886
plasma membrane
|
TAS
Reactome:R-HSA-8936676 |
ACCEPT |
Summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal, well-supported localization for NRAS.
Reason: The plasma-membrane localization is correct and is the core signaling site. The many Reactome rows are redundant reaction-level participations that all assert the same cellular-component placement.
Supporting Evidence:
file:human/NRAS/NRAS-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.
|
|
GO:0005794
Golgi apparatus
|
IDA
PMID:21968647 PAQR10 and PAQR11 mediate Ras signaling in the Golgi apparat... |
ACCEPT |
Summary: NRAS localizes to and is activated at the Golgi apparatus; the Golgi-resident proteins PAQR10/PAQR11 interact with NRAS and elevate its Golgi localization and activation, providing direct evidence for Golgi localization.
Reason: Direct experimental support for the core Golgi-apparatus localization, consistent with the Golgi-membrane annotations and the PM-Golgi shuttling model. (The part_of qualifier is atypical for an organelle localization, but the underlying Golgi localization is sound.)
Supporting Evidence:
PMID:21968647
Overexpression of PAQR10/PAQR11 markedly elevates Golgi localization of HRas, NRas and KRas4A, but not KRas4B.
|
Q: To what extent are NRAS-specific (versus pan-RAS) downstream signaling outputs and effector preferences attributable to its hypervariable region and its distinctive palmitoylation/depalmitoylation-driven PM-Golgi trafficking?
Suggested experts: McCormick F, Bastiaens PIH
Q: Should NRAS receive a distinct molecular-function annotation for RAF/effector binding (e.g., a Ras-effector engagement term) given the many curated effector interactions currently captured only as generic protein binding?
Suggested experts: Thomas GV
Experiment: Use acylation-cycle mutants (e.g., Cys181Ser) and ABHD17/ZDHHC9 perturbations combined with FRET-based Ras activity biosensors and phospho-ERK readouts to map how subcellular localization governs NRAS-driven MAPK activation.
Hypothesis: NRAS effector engagement and signaling output are quantitatively shaped by its palmitoylation-dependent localization between plasma membrane and Golgi.
Type: live-cell signaling and localization assay
Experiment: Compare effector co-immunoprecipitation, GTP-loading, and downstream ERK activation for wild-type, S89A, and oncogenic (Q61R) NRAS in STK19-proficient versus STK19-deficient cells.
Hypothesis: Ser-89 phosphorylation by STK19 selectively enhances oncogenic NRAS effector binding and MAPK output.
Type: biochemical effector-binding and phosphorylation assay
Research journal for the GO annotation review of human NRAS (GTPase NRas, HGNC:7989,
UniProt P01111). There was no pre-generated deep-research file, so literature was
assembled from the publications/ cache (PMIDs cited in NRAS-goa.tsv) and the UniProt
record (NRAS-uniprot.txt).
NRAS ("Neuroblastoma RAS viral oncogene homolog") is one of the three canonical RAS
small GTPases (HRAS, KRAS, NRAS). It is a 189-aa precursor (mature 1-186 after CAAX
processing) belonging to the small GTPase superfamily, Ras family
[file:human/NRAS/NRAS-uniprot.txt "Belongs to the small GTPase superfamily. Ras family."].
NRAS is anchored to membranes via C-terminal lipidation: S-farnesyl at Cys-186 and
S-palmitoyl at Cys-181 [UniProt LIPID 181 (palmitoyl), 186 (farnesyl);
PMID:2661017 "All ras proteins are polyisoprenylated but only some are palmitoylated"].
A constitutive de/re-palmitoylation cycle drives rapid shuttling between the plasma
membrane and the Golgi apparatus:
- PMID:15705808
- PMID:15705808
- Palmitoylated by the ZDHHC9-GOLGA7 complex; depalmitoylated by ABHD17A/B/C
[UniProt PTM; PMID:26701913 "ABHD17 catalytic activity is required for N-Ras depalmitoylation and re-localization to internal cellular membranes"].
- Cys-181-to-Ser mutation abolishes plasma membrane localization
[UniProt MUTAGEN 181 "C->S: Loss of plasma membrane localization." (PMID:26701913)].
- UniProt SUBCELLULAR LOCATION: Cell membrane (lipid-anchor, cytoplasmic side) and
Golgi apparatus membrane; "Shuttles between the plasma membrane and the Golgi apparatus."
Both supported experimentally by PMID:15705808 and PMID:26701913.
So plasma membrane and Golgi membrane are both bona-fide experimentally supported
locations. Endoplasmic reticulum membrane appears in Reactome RAS-processing reactions
(farnesylation/ICMT/RCE1 occur at the ER) — plausible as a transient processing site
but only TAS-supported.
Active GTP-bound NRAS transduces signals from receptor tyrosine kinases (activated by
GEFs such as SOS1, RasGRP) to downstream effectors:
- RAF kinases (ARAF, BRAF, RAF1) -> MEK -> ERK MAPK cascade. UniProt INTERACTION lists
direct binding to ARAF (Q96II5), BRAF (P15056), RAF1 (P04049).
- PI3K (binds PIK3R1 P27986-2 per UniProt INTERACTION; Reactome R-HSA-9658253 "RAS:GTP binds PI3K").
- RalGDS / RGL3 (Q3MIN7), RIN1 (Q13671) effectors (UniProt INTERACTION; IntAct GOA lines).
- STK19 phosphorylates NRAS at Ser-89 to enhance binding to downstream effectors and
promote oncogenic NRAS-driven melanocyte transformation
PMID:30712867.
PMID:30712867 is the experimental basis (IDA) for both GTPase activity and Ras protein
signal transduction in GOA, and the UniProt FUNCTION statement (ECO:0000269|PubMed:30712867).
NRAS (GTP-bound) binds the SHOC2-PP1C (PPP1CA/B/C) holophosphatase complex, a RAF
activator; this complex dephosphorylates the inhibitory S259 site on RAF.
- [file:human/NRAS/NRAS-uniprot.txt "Interacts (active GTP-bound form) with both SHOC2 and PP1c (all isoforms) to form a tertiary complex; SHOC2 and PP1c preferably bind M-Ras/MRAS, but they also bind K-Ras/KRAS, N-Ras/NRAS and H-Ras/HRAS"]
- ComplexPortal CPX-26354 "SHOC2-NRAS-PPP1CA complex"; GOA NAS line GO:0046579
(positive regulation of Ras protein signal transduction, PMID:35831509) reflects this.
id: P01111
gene_symbol: NRAS
product_type: PROTEIN
status: INITIALIZED
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: NRAS is one of the three canonical human RAS small GTPases (with HRAS and KRAS).
It is a peripheral membrane protein anchored to the cytoplasmic face of cellular membranes
through C-terminal lipidation (farnesylation at Cys-186 and palmitoylation at Cys-181) and
functions as a binary molecular switch that binds GDP/GTP and possesses intrinsic GTPase
activity. Cycling between an inactive GDP-bound and an active GTP-bound state under the control
of guanine nucleotide exchange factors (GEFs such as SOS1 and RasGRP) and GTPase-activating
proteins (GAPs), active GTP-bound NRAS transduces signals from receptor tyrosine kinases to
downstream effectors, principally the RAF-MEK-ERK (MAPK) cascade and PI3K, thereby promoting
cell proliferation, survival and differentiation. NRAS undergoes a constitutive
de/re-palmitoylation acylation cycle that drives rapid shuttling between the plasma membrane
and the Golgi apparatus, providing spatial control of signaling. Activating somatic and
germline mutations at codons 12, 13 and 61 impair GTP hydrolysis and lock NRAS in its active
state, a major oncogenic and developmental-disorder mechanism.
existing_annotations:
- term:
id: GO:0005886
label: plasma membrane
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: is_active_in
review:
summary: NRAS is a lipid-anchored peripheral membrane protein active on the cytoplasmic
face of the plasma membrane, where GTP-bound NRAS engages RAF and other effectors.
This is a core, well-supported phylogenetic localization for the RAS family.
action: ACCEPT
reason: Plasma membrane is the principal site of action for NRAS signaling and is strongly
supported across orthologs (IBA) and by direct experimental evidence in human cells.
supported_by:
- reference_id: file:human/NRAS/NRAS-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.'
- reference_id: PMID:26701913
supporting_text: ABHD17 catalytic activity is required for N-Ras depalmitoylation and
re-localization to internal cellular membranes.
- term:
id: GO:0007265
label: Ras protein signal transduction
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: Ras protein signal transduction is the defining biological process of NRAS,
which acts as a GTP/GDP-regulated switch transducing receptor tyrosine kinase input
to downstream effectors (RAF-MEK-ERK, PI3K). Conserved across the RAS family.
action: ACCEPT
reason: This is the central core biological process for NRAS, supported phylogenetically
(IBA) and by direct experimental evidence (see the IDA row for PMID:30712867).
supported_by:
- reference_id: PMID:30712867
supporting_text: STK19 phosphorylates NRAS to enhance its binding to its downstream
effectors and promotes oncogenic NRAS-mediated melanocyte malignant transformation.
- term:
id: GO:0008284
label: positive regulation of cell population proliferation
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: Active NRAS signaling through the MAPK and PI3K pathways promotes cell
proliferation, and oncogenic NRAS mutations drive uncontrolled proliferation. This is a
genuine but downstream consequence of NRAS signal transduction.
action: KEEP_AS_NON_CORE
reason: Promotion of proliferation is a real, conserved role of RAS GTPases but is a
downstream physiological output of the core GTPase/signal-transduction function rather
than the molecular activity itself. Retained as a non-core process.
supported_by:
- reference_id: PMID:30712867
supporting_text: Activating mutations in NRAS account for 20%-30% of melanoma.
- term:
id: GO:0003924
label: GTPase activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: enables
review:
summary: NRAS hydrolyzes GTP to GDP (EC 3.6.5.2), the catalytic activity underlying its
switch behavior. Intrinsic GTPase activity is the canonical molecular function of all
RAS-family proteins and is impaired by oncogenic codon-12/13/61 mutations.
action: ACCEPT
reason: GTPase activity is a core molecular function, supported phylogenetically (IBA) and
directly (PMID:30712867; UniProt FUNCTION/CATALYTIC ACTIVITY).
supported_by:
- reference_id: file:human/NRAS/NRAS-uniprot.txt
supporting_text: Ras proteins bind GDP/GTP and possess intrinsic GTPase activity.
- reference_id: file:human/NRAS/NRAS-uniprot.txt
supporting_text: Reaction=GTP + H2O = GDP + phosphate + H(+); ... EC=3.6.5.2
- term:
id: GO:0000139
label: Golgi membrane
evidence_type: IEA
original_reference_id: GO_REF:0000044
qualifier: located_in
review:
summary: NRAS localizes to the Golgi apparatus membrane as part of its de/re-palmitoylation
acylation cycle, shuttling between the plasma membrane and Golgi. UniProt subcellular
location vocabulary maps to this term.
action: ACCEPT
reason: Golgi membrane is an experimentally supported core localization for NRAS (see EXP
rows PMID:15705808, PMID:26701913); the UniProt SubCell IEA mapping is consistent.
supported_by:
- reference_id: PMID:15705808
supporting_text: driving their rapid exchange between the plasma membrane (PM) and the
Golgi apparatus.
- term:
id: GO:0000165
label: MAPK cascade
evidence_type: IEA
original_reference_id: GO_REF:0000117
qualifier: involved_in
review:
summary: NRAS is an upstream activator of the RAF-MEK-ERK MAPK cascade; GTP-bound NRAS
recruits and activates RAF kinases, initiating the cascade.
action: ACCEPT
reason: MAPK cascade is a core biological process for NRAS, also supported by Reactome TAS
(RAF/MAP kinase cascade) and by direct effector-binding evidence.
supported_by:
- reference_id: PMID:18641128
supporting_text: eNOS selectively activates N-Ras but not K-Ras on the Golgi complex of
T cells engaged with APC.
- term:
id: GO:0003924
label: GTPase activity
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: enables
review:
summary: InterPro small-GTPase signature (IPR001806) maps NRAS to GTPase activity, its
canonical catalytic molecular function.
action: ACCEPT
reason: Correct InterPro2GO mapping consistent with the IBA/IDA/ISS GTPase activity rows.
supported_by:
- reference_id: file:human/NRAS/NRAS-uniprot.txt
supporting_text: Ras proteins bind GDP/GTP and possess intrinsic GTPase activity.
- term:
id: GO:0003925
label: G protein activity
evidence_type: IEA
original_reference_id: GO_REF:0000003
qualifier: enables
review:
summary: G protein activity is the EC-mapped (EC 3.6.5.2) molecular function for the small
monomeric GTPase enzyme class. For NRAS this is the same underlying GTP-hydrolyzing
activity captured more specifically as GTPase activity (GO:0003924).
action: KEEP_AS_NON_CORE
reason: The term is not wrong, but GTPase activity (GO:0003924) is the more standard and
specific molecular-function descriptor for RAS proteins and is already present. Retained
as a non-core duplicate of the core enzymatic activity rather than the preferred term.
supported_by:
- reference_id: file:human/NRAS/NRAS-uniprot.txt
supporting_text: Reaction=GTP + H2O = GDP + phosphate + H(+); ... EC=3.6.5.2
- term:
id: GO:0005525
label: GTP binding
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: enables
review:
summary: NRAS binds GTP (and GDP) via its conserved P-loop and G-box motifs; nucleotide
binding is the basis of its switch function. InterPro small-GTPase signatures map here.
action: ACCEPT
reason: GTP binding is a core molecular function directly supported by the crystal structure
(GDP-bound) and the conserved GTP-binding sites in the UniProt record.
supported_by:
- reference_id: file:human/NRAS/NRAS-uniprot.txt
supporting_text: Ras proteins bind GDP/GTP and possess intrinsic GTPase activity.
- term:
id: GO:0005886
label: plasma membrane
evidence_type: IEA
original_reference_id: GO_REF:0000044
qualifier: located_in
review:
summary: Plasma membrane localization of NRAS via the UniProt SubCell vocabulary mapping,
consistent with its lipid-anchored peripheral membrane attachment.
action: ACCEPT
reason: Core localization, redundant with the IBA/IDA/EXP plasma membrane rows.
supported_by:
- reference_id: file:human/NRAS/NRAS-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.'
- term:
id: GO:0007165
label: signal transduction
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: involved_in
review:
summary: Generic signal transduction is correct for NRAS but is a broad parent of the more
specific and better-supported Ras protein signal transduction (GO:0007265) and MAPK
cascade (GO:0000165) annotations already present.
action: KEEP_AS_NON_CORE
reason: Not wrong, but less informative than the specific Ras-signal-transduction terms.
Retained as a non-core broad classifier.
supported_by:
- reference_id: PMID:30712867
supporting_text: STK19 phosphorylates NRAS to enhance its binding to its downstream
effectors and promotes oncogenic NRAS-mediated melanocyte malignant transformation.
- term:
id: GO:0016020
label: membrane
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: located_in
review:
summary: Generic membrane localization from the InterPro small-GTPase mapping. NRAS is a
membrane-anchored protein, but the specific plasma-membrane and Golgi-membrane terms are
far more informative.
action: MARK_AS_OVER_ANNOTATED
reason: The bare membrane term loses the diagnostic plasma-membrane/Golgi-membrane
specificity that is well established for NRAS.
supported_by:
- reference_id: file:human/NRAS/NRAS-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.'
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:18641128
qualifier: enables
review:
summary: IntAct binary interaction (NRAS with RAF1/CRAF, P04049). This reflects NRAS
binding its downstream RAF effector, consistent with its role activating the MAPK cascade,
but it is captured only as the uninformative generic protein binding term.
action: MARK_AS_OVER_ANNOTATED
reason: Bare protein binding (GO:0005515) is uninformative per curation guidelines. The
biologically meaningful RAS-RAF effector engagement is already represented by the Ras
protein signal transduction and MAPK cascade process annotations; the underlying study
concerns eNOS-regulated N-Ras activation on the Golgi.
supported_by:
- reference_id: PMID:18641128
supporting_text: eNOS selectively activates N-Ras but not K-Ras on the Golgi complex of
T cells engaged with APC.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:20080631
qualifier: enables
review:
summary: IntAct binary interaction (NRAS with RAF1/CRAF, P04049) from a study of Ras
membrane orientation and nanodomain localization. Captured as the generic protein binding
term.
action: MARK_AS_OVER_ANNOTATED
reason: Bare protein binding (GO:0005515) is uninformative. The RAS-RAF effector interaction
and membrane-nanodomain context are already represented by the signal-transduction and
plasma-membrane annotations.
supported_by:
- reference_id: PMID:20080631
supporting_text: Ras membrane orientation and nanodomain localization generate isoform
diversity.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:21478863
qualifier: enables
review:
summary: IntAct binary interactions (NRAS with RAF1 P04049, BRAF P15056, Braf P28028, Raf1
Q99N57) from a study of ERK/PDE4-driven RAF isoform switching in melanoma. Reflects NRAS
binding RAF effectors, captured only as generic protein binding.
action: MARK_AS_OVER_ANNOTATED
reason: Bare protein binding (GO:0005515) is uninformative. The RAS-RAF effector engagement
is already represented by the Ras protein signal transduction and MAPK cascade processes.
supported_by:
- reference_id: PMID:21478863
supporting_text: ERK and PDE4 cooperate to induce RAF isoform switching in melanoma.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:28514442
qualifier: enables
review:
summary: IntAct interaction (NRAS with RIN1, Q13671) from a high-throughput interactome map
defining protein communities and disease networks. Captured as generic protein binding.
action: MARK_AS_OVER_ANNOTATED
reason: Bare protein binding (GO:0005515) from a large-scale interactome screen is
uninformative as a molecular-function annotation; it does not define a specific NRAS
activity beyond interactions already implied by its effector/regulator network.
supported_by:
- reference_id: PMID:28514442
supporting_text: Architecture of the human interactome defines protein communities and
disease networks.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:30194290
qualifier: enables
review:
summary: IntAct interactions (NRAS with RAF1 P04049 and BRAF P15056) from a study
interrogating RAS-isoform interactomes (identified PIP5K1A as a KRAS-specific
vulnerability). Reflects NRAS-RAF effector binding, captured as generic protein binding.
action: MARK_AS_OVER_ANNOTATED
reason: Bare protein binding (GO:0005515) is uninformative; the RAS-RAF effector interaction
is already represented by the signal-transduction/MAPK annotations.
supported_by:
- reference_id: PMID:30194290
supporting_text: Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A
as a KRAS-specific vulnerability.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:31209342
qualifier: enables
review:
summary: IntAct interaction (NRAS with RABGGTB/GGTase component P49354) from the study
identifying GGTase3, a geranylgeranyltransferase. Captured as generic protein binding.
action: MARK_AS_OVER_ANNOTATED
reason: Bare protein binding (GO:0005515) is uninformative. NRAS lipidation/prenylation is
relevant to its membrane targeting, but this interaction is not by itself an informative
molecular-function annotation.
supported_by:
- reference_id: PMID:31209342
supporting_text: GGTase3 is a newly identified geranylgeranyltransferase targeting a
ubiquitin ligase.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:31980649
qualifier: enables
review:
summary: IntAct interaction (NRAS with RAF1, P04049) from a study of EGFR-network rewiring
in KRAS(G13D) colorectal cancer cells. Captured as generic protein binding.
action: MARK_AS_OVER_ANNOTATED
reason: Bare protein binding (GO:0005515) is uninformative; RAS-RAF effector engagement is
already represented by the signal-transduction/MAPK annotations.
supported_by:
- reference_id: PMID:31980649
supporting_text: Extensive rewiring of the EGFR network in colorectal cancer cells
expressing transforming levels of KRAS(G13D).
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32296183
qualifier: enables
review:
summary: IntAct interactions (NRAS with RAF1 P04049, RAP1GDS1/SmgGDS P52306-5, RIN1 Q13671,
RGL3 Q3MIN7, ARAF Q96II5) from a reference map of the human binary protein interactome.
Includes genuine effectors/regulators but captured only as generic protein binding.
action: MARK_AS_OVER_ANNOTATED
reason: Bare protein binding (GO:0005515) from a large binary interactome map is
uninformative as a molecular function; the relevant effector/GEF interactions are already
represented by the Ras signal-transduction annotations.
supported_by:
- reference_id: PMID:32296183
supporting_text: A reference map of the human binary protein interactome.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32707033
qualifier: enables
review:
summary: IntAct interaction (NRAS with BRAF, P15056) from a kinase interaction network
study. Reflects NRAS-RAF effector binding, captured as generic protein binding.
action: MARK_AS_OVER_ANNOTATED
reason: Bare protein binding (GO:0005515) is uninformative; the RAS-RAF effector interaction
is already represented by the signal-transduction/MAPK annotations.
supported_by:
- reference_id: PMID:32707033
supporting_text: Kinase Interaction Network Expands Functional and Disease Roles of Human
Kinases.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32814053
qualifier: enables
review:
summary: IntAct interaction (NRAS with PIK3R1 isoform P27986-2) from an interactome map of
neurodegenerative disease proteins. PIK3R1 is the PI3K regulatory subunit, an NRAS
effector arm, but captured as generic protein binding.
action: MARK_AS_OVER_ANNOTATED
reason: Bare protein binding (GO:0005515) is uninformative; the PI3K effector engagement is
already implied by the Ras signal-transduction annotations.
supported_by:
- reference_id: PMID:32814053
supporting_text: Interactome Mapping Provides a Network of Neurodegenerative Disease
Proteins and Uncovers Widespread Protein Aggregation in Affected Brains.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:33961781
qualifier: enables
review:
summary: IntAct interaction (NRAS with RIN1, Q13671) from dual proteome-scale interactome
networks. Captured as generic protein binding.
action: MARK_AS_OVER_ANNOTATED
reason: Bare protein binding (GO:0005515) from a large-scale interactome screen is
uninformative as a molecular-function annotation.
supported_by:
- reference_id: PMID:33961781
supporting_text: Dual proteome-scale networks reveal cell-specific remodeling of the human
interactome.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:34591642
qualifier: enables
review:
summary: IntAct interactions (NRAS with RAF1 P04049, BRAF P15056, RIN1 Q13671) from a
protein network map of head and neck cancer. Captured as generic protein binding.
action: MARK_AS_OVER_ANNOTATED
reason: Bare protein binding (GO:0005515) is uninformative; the RAS-RAF/effector interactions
are already represented by the signal-transduction/MAPK annotations.
supported_by:
- reference_id: PMID:34591642
supporting_text: A protein network map of head and neck cancer reveals PIK3CA mutant drug
sensitivity.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:35512704
qualifier: enables
review:
summary: IntAct interaction (NRAS with BRAF, P15056) from a study of mutation-directed
neo-protein-protein interactions in cancer. Captured as generic protein binding.
action: MARK_AS_OVER_ANNOTATED
reason: Bare protein binding (GO:0005515) is uninformative; the RAS-RAF effector interaction
is already represented by the signal-transduction/MAPK annotations.
supported_by:
- reference_id: PMID:35512704
supporting_text: Systematic discovery of mutation-directed neo-protein-protein
interactions in cancer.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:35839996
qualifier: enables
review:
summary: IntAct interactions (NRAS with RAF1 P04049, RABGGTB P49354, and Q96JH8) from a
proteomic study of isoform-specific and nucleotide-dependent RAS interactions. Captured
as generic protein binding.
action: MARK_AS_OVER_ANNOTATED
reason: Bare protein binding (GO:0005515) is uninformative; nucleotide-dependent effector
interactions are already represented by the Ras signal-transduction annotations.
supported_by:
- reference_id: PMID:35839996
supporting_text: A Proteomic Approach Identifies Isoform-Specific and Nucleotide-Dependent
RAS Interactions.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:40205054
qualifier: enables
review:
summary: IntAct interaction (NRAS with RIN1, Q13671) from a multimodal cell-map study.
Captured as generic protein binding.
action: MARK_AS_OVER_ANNOTATED
reason: Bare protein binding (GO:0005515) from a large-scale mapping study is uninformative
as a molecular-function annotation.
supported_by:
- reference_id: PMID:40205054
supporting_text: Multimodal cell maps as a foundation for structural and functional
genomics.
- term:
id: GO:0000165
label: MAPK cascade
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5673001
qualifier: involved_in
review:
summary: Reactome places NRAS in the RAF/MAP kinase cascade, consistent with its core role
as an upstream activator of RAF-MEK-ERK signaling.
action: ACCEPT
reason: Core biological process, concordant with the IEA MAPK cascade row and effector-binding
evidence.
supported_by:
- reference_id: Reactome:R-HSA-5673001
supporting_text: RAF/MAP kinase cascade.
- term:
id: GO:0046579
label: positive regulation of Ras protein signal transduction
evidence_type: NAS
original_reference_id: PMID:35831509
qualifier: involved_in
review:
summary: Active GTP-bound NRAS binds the SHOC2-PP1C holophosphatase complex, which
dephosphorylates inhibitory sites on RAF to promote RAF activation, positively regulating
Ras/MAPK signaling. This NAS annotation derives from the ComplexPortal SHOC2-NRAS-PPP1CA
complex.
action: KEEP_AS_NON_CORE
reason: This represents NRAS participation in a positive-feedback/effector-activation complex
rather than its core intrinsic GTPase switch activity. It is a valid, more specialized
process, retained as non-core.
supported_by:
- reference_id: file:human/NRAS/NRAS-uniprot.txt
supporting_text: Interacts (active GTP-bound form) with both SHOC2 and PP1c (all isoforms)
to form a tertiary complex; SHOC2 and PP1c preferably bind M-Ras/MRAS, but they also bind
K-Ras/KRAS, N-Ras/NRAS and H-Ras/HRAS
- term:
id: GO:0005886
label: plasma membrane
evidence_type: IDA
original_reference_id: GO_REF:0000052
qualifier: located_in
review:
summary: Immunofluorescence (Human Protein Atlas) localizes NRAS to the plasma membrane,
consistent with its lipid-anchored membrane attachment.
action: ACCEPT
reason: Direct (IDA) support for the core plasma-membrane localization.
supported_by:
- reference_id: file:human/NRAS/NRAS-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.'
- term:
id: GO:0000139
label: Golgi membrane
evidence_type: EXP
original_reference_id: PMID:15705808
qualifier: located_in
review:
summary: NRAS is experimentally localized to the Golgi apparatus membrane, where the
de/re-palmitoylation acylation cycle traps farnesylated Ras before redirection to the
plasma membrane.
action: ACCEPT
reason: Direct experimental support for core Golgi-membrane localization as part of the
PM-Golgi shuttling cycle.
supported_by:
- reference_id: PMID:15705808
supporting_text: Depalmitoylation redistributes farnesylated Ras in all membranes,
followed by repalmitoylation and trapping of Ras at the Golgi, from where it is
redirected to the PM via the secretory pathway.
- term:
id: GO:0000139
label: Golgi membrane
evidence_type: EXP
original_reference_id: PMID:26701913
qualifier: located_in
review:
summary: NRAS localizes to Golgi/internal membranes, with ABHD17 depalmitoylase activity
controlling its palmitate turnover and relocalization between plasma membrane and internal
membranes.
action: ACCEPT
reason: Direct experimental support for core Golgi-membrane localization in the context of
palmitoylation-dependent trafficking.
supported_by:
- reference_id: PMID:26701913
supporting_text: ABHD17 catalytic activity is required for N-Ras depalmitoylation and
re-localization to internal cellular membranes.
- term:
id: GO:0003924
label: GTPase activity
evidence_type: ISS
original_reference_id: GO_REF:0000024
qualifier: enables
review:
summary: GTPase activity transferred by sequence similarity from KRAS (P01116). NRAS shares
the canonical RAS catalytic machinery and intrinsic GTPase activity.
action: ACCEPT
reason: Correct similarity-based assignment of the core GTPase molecular function, fully
concordant with the IBA/IDA evidence.
supported_by:
- reference_id: file:human/NRAS/NRAS-uniprot.txt
supporting_text: Ras proteins bind GDP/GTP and possess intrinsic GTPase activity.
- term:
id: GO:0005886
label: plasma membrane
evidence_type: EXP
original_reference_id: PMID:15705808
qualifier: located_in
review:
summary: NRAS is experimentally localized to the plasma membrane, the principal signaling
site, as part of the PM-Golgi acylation shuttling cycle.
action: ACCEPT
reason: Direct experimental support for the core plasma-membrane localization.
supported_by:
- reference_id: PMID:15705808
supporting_text: driving their rapid exchange between the plasma membrane (PM) and the
Golgi apparatus.
- term:
id: GO:0005886
label: plasma membrane
evidence_type: EXP
original_reference_id: PMID:26701913
qualifier: located_in
review:
summary: NRAS plasma-membrane localization is palmitoylation-dependent; ABHD17 depalmitoylase
activity drives N-Ras relocalization from the plasma membrane to internal membranes, and
loss of palmitoylation (Cys181Ser) abolishes plasma-membrane localization.
action: ACCEPT
reason: Direct experimental support for the core plasma-membrane localization.
supported_by:
- reference_id: PMID:26701913
supporting_text: ABHD17 catalytic activity is required for N-Ras depalmitoylation and
re-localization to internal cellular membranes.
- term:
id: GO:0003924
label: GTPase activity
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9649736
qualifier: enables
review:
summary: Reactome attributes GTPase activity to NRAS, its canonical catalytic molecular
function.
action: ACCEPT
reason: Concordant with the core GTPase activity annotations (IBA/IDA/ISS/IEA).
supported_by:
- reference_id: file:human/NRAS/NRAS-uniprot.txt
supporting_text: Ras proteins bind GDP/GTP and possess intrinsic GTPase activity.
- term:
id: GO:0000139
label: Golgi membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9647980
qualifier: located_in
review: &golgi_tas
summary: Reactome RAS-processing/localization events place NRAS at the Golgi apparatus
membrane, a bona-fide localization in its PM-Golgi shuttling cycle.
action: ACCEPT
reason: Concordant with the experimentally supported core Golgi-membrane localization.
supported_by:
- reference_id: PMID:15705808
supporting_text: driving their rapid exchange between the plasma membrane (PM) and the
Golgi apparatus.
- term:
id: GO:0000139
label: Golgi membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9647982
qualifier: located_in
review: *golgi_tas
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9647977
qualifier: located_in
review: &er_tas
summary: Reactome RAS-processing events localize NRAS to the endoplasmic reticulum membrane,
where post-translational CAAX processing (RCE1/ICMT) of newly farnesylated Ras occurs en
route to the Golgi and plasma membrane.
action: KEEP_AS_NON_CORE
reason: ER membrane is a transient processing/transit site rather than the principal signaling
location (plasma membrane/Golgi). Retained as a non-core localization supported only by
Reactome pathway knowledge.
supported_by:
- reference_id: PMID:15705808
supporting_text: from where it is redirected to the PM via the secretory pathway.
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9647978
qualifier: located_in
review: *er_tas
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9647982
qualifier: located_in
review: *er_tas
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9647999
qualifier: located_in
review: *er_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-1168636
qualifier: located_in
review: &pm_tas
summary: Reactome maps NRAS as a participant located at the plasma membrane across numerous
RTK-to-RAS activation and RAF/MAPK signaling reactions. Plasma membrane is the principal,
well-supported localization for NRAS.
action: ACCEPT
reason: The plasma-membrane localization is correct and is the core signaling site. The many
Reactome rows are redundant reaction-level participations that all assert the same
cellular-component placement.
supported_by:
- reference_id: file:human/NRAS/NRAS-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.'
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-1225951
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-1225957
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-1250383
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-1306972
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-1433471
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-170986
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-177938
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-177945
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-186834
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-210977
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-2179407
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-2424477
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-392054
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5218845
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5621573
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5624486
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5624492
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5624494
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5637806
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5637808
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5654392
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5654402
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5654413
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5654426
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5654600
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5654618
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5654647
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5654663
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5655241
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5655277
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5655326
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5655347
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5658231
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5658435
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5672950
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5672965
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5672966
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5672969
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5672972
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5672973
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5672978
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5672980
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5674018
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5674022
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5675417
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5675431
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5675433
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6802837
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8851827
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8851877
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8851899
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8941613
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8941618
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8941623
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8941628
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8981353
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8981355
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9607304
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9632906
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9632918
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9634418
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9647980
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9647994
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9649733
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9649735
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9649736
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9653108
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9656209
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9656211
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9656212
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9656213
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9656214
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9656215
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9657599
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9657603
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9657606
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9657608
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9658253
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9664991
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9665009
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9665404
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9665408
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9665700
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9665707
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9670436
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9672163
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9672170
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9695853
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9703441
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9647978
qualifier: located_in
review:
summary: Reactome localizes newly synthesized, pre-processed (farnesylated but not yet
membrane-anchored) NRAS to the cytosol during RAS processing.
action: KEEP_AS_NON_CORE
reason: Cytosolic localization applies transiently to nascent unprocessed NRAS; the mature,
functionally active protein is membrane-anchored. Retained as a non-core processing-stage
location.
supported_by:
- reference_id: file:human/NRAS/NRAS-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor; Cytoplasmic side.'
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6802834
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6802908
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6802918
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6802922
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6802924
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6802925
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6802926
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6802937
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6802941
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6802942
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6802943
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6803233
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6803234
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6803240
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8936731
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9651280
qualifier: located_in
review: *pm_tas
- term:
id: GO:0003924
label: GTPase activity
evidence_type: IDA
original_reference_id: PMID:30712867
qualifier: enables
review:
summary: Direct experimental study of NRAS function, including characterization of the
oncogenic Q61R variant and STK19-mediated Ser-89 phosphorylation; UniProt cites this work
(ECO:0000269|PubMed:30712867) for NRAS GDP/GTP binding and intrinsic GTPase activity.
action: ACCEPT
reason: Provides direct experimental (IDA) support for the core GTPase molecular function of
NRAS.
supported_by:
- reference_id: file:human/NRAS/NRAS-uniprot.txt
supporting_text: Ras proteins bind GDP/GTP and possess intrinsic GTPase activity.
{ECO:0000269|PubMed:30712867}.
- term:
id: GO:0007265
label: Ras protein signal transduction
evidence_type: IDA
original_reference_id: PMID:30712867
qualifier: involved_in
review:
summary: NRAS transduces signals to downstream effectors; STK19 phosphorylates NRAS at
Ser-89 to enhance effector binding and promote oncogenic NRAS-driven melanocyte
transformation, providing direct evidence for NRAS signal transduction.
action: ACCEPT
reason: Direct experimental (IDA) support for the core Ras-protein-signal-transduction
process.
supported_by:
- reference_id: PMID:30712867
supporting_text: STK19 phosphorylates NRAS to enhance its binding to its downstream
effectors and promotes oncogenic NRAS-mediated melanocyte malignant transformation.
- term:
id: GO:0044877
label: protein-containing complex binding
evidence_type: IDA
original_reference_id: PMID:23209302
qualifier: enables
review:
summary: This annotation derives from a study focused on KIF14 and Rap1a-Radil signaling in
breast cancer; NRAS is not the subject of that work, and the protein-containing complex
binding term is generic.
action: MARK_AS_OVER_ANNOTATED
reason: The cited paper does not characterize a specific NRAS molecular function; the generic
complex-binding term adds little beyond NRAS's established effector/regulator interactions
already captured by its signal-transduction annotations.
supported_by:
- reference_id: PMID:23209302
supporting_text: KIF14 negatively regulates Rap1a-Radil signaling during breast cancer
progression.
- term:
id: GO:0001938
label: positive regulation of endothelial cell proliferation
evidence_type: IMP
original_reference_id: PMID:23619365
qualifier: involved_in
review:
summary: In endothelial cells, miR-146a downregulates NRAS and thereby attenuates
angiogenesis, implying that NRAS normally supports endothelial cell proliferation and
angiogenesis. This is a tissue-specific downstream output of NRAS/MAPK signaling.
action: KEEP_AS_NON_CORE
reason: The role in endothelial cell proliferation is a peripheral, cell-type-specific
consequence of the core NRAS signaling function rather than its defining activity. Retained
as a non-core process.
supported_by:
- reference_id: PMID:23619365
supporting_text: which attenuated angiogenesis through downregulation of NRAS.
- term:
id: GO:0070821
label: tertiary granule membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6798747
qualifier: located_in
review:
summary: This Reactome annotation (neutrophil degranulation pathway) places NRAS at the
tertiary granule membrane in neutrophils. It reflects pathway-level granule-proteome
membership rather than a core functional localization.
action: MARK_AS_OVER_ANNOTATED
reason: Tertiary granule membrane is a cell-type-specific membrane compartment derived from
a degranulation proteome pathway; it is far less informative than the established plasma
membrane/Golgi localizations and does not represent the core site of NRAS signaling.
supported_by:
- reference_id: Reactome:R-HSA-6798747
supporting_text: Neutrophil degranulation.
- term:
id: GO:0016020
label: membrane
evidence_type: HDA
original_reference_id: PMID:19946888
qualifier: located_in
review:
summary: NRAS was detected in a high-throughput NK-cell membrane proteome. Generic membrane
localization is consistent with NRAS being a membrane-anchored protein but is much less
informative than its specific plasma-membrane/Golgi-membrane localizations.
action: MARK_AS_OVER_ANNOTATED
reason: The bare membrane term from a proteomic dataset loses the diagnostic
plasma-membrane/Golgi specificity already well established for NRAS.
supported_by:
- reference_id: PMID:19946888
supporting_text: Defining the membrane proteome of NK cells.
- term:
id: GO:0070062
label: extracellular exosome
evidence_type: HDA
original_reference_id: PMID:20458337
qualifier: located_in
review:
summary: NRAS was detected in a proteomic survey of B-cell exosomes. This is a
high-throughput co-purification rather than evidence of a functional exosomal role.
action: MARK_AS_OVER_ANNOTATED
reason: Exosomal detection of a membrane-anchored signaling GTPase likely reflects membrane
co-isolation; it does not represent a core localization or function and over-annotates the
established plasma-membrane/Golgi biology.
supported_by:
- reference_id: PMID:20458337
supporting_text: MHC class II-associated proteins in B-cell exosomes and potential
functional implications for exosome biogenesis.
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6798747
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6802914
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6802915
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6802916
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6802919
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6802921
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6803230
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005886
label: plasma membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8936676
qualifier: located_in
review: *pm_tas
- term:
id: GO:0005794
label: Golgi apparatus
evidence_type: IDA
original_reference_id: PMID:21968647
qualifier: part_of
review:
summary: NRAS localizes to and is activated at the Golgi apparatus; the Golgi-resident
proteins PAQR10/PAQR11 interact with NRAS and elevate its Golgi localization and activation,
providing direct evidence for Golgi localization.
action: ACCEPT
reason: Direct experimental support for the core Golgi-apparatus localization, consistent
with the Golgi-membrane annotations and the PM-Golgi shuttling model. (The part_of qualifier
is atypical for an organelle localization, but the underlying Golgi localization is sound.)
supported_by:
- reference_id: PMID:21968647
supporting_text: Overexpression of PAQR10/PAQR11 markedly elevates Golgi localization of
HRas, NRas and KRas4A, but not KRas4B.
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO
terms
findings: []
- id: GO_REF:0000003
title: Gene Ontology annotation based on Enzyme Commission mapping
findings: []
- id: GO_REF:0000024
title: Manual transfer of experimentally-verified manual GO annotation data to orthologs
by curator judgment of sequence similarity
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000044
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
vocabulary mapping, accompanied by conservative changes to GO terms applied by
UniProt
findings: []
- id: GO_REF:0000052
title: Gene Ontology annotation based on curation of immunofluorescence data
findings: []
- id: GO_REF:0000117
title: Electronic Gene Ontology annotations created by ARBA machine learning models
findings: []
- id: PMID:15705808
title: An acylation cycle regulates localization and activity of palmitoylated Ras
isoforms.
findings:
- statement: A constitutive de/re-palmitoylation acylation cycle drives rapid exchange of
N-Ras between the plasma membrane and the Golgi apparatus.
supporting_text: the specific subcellular distribution of H- and Nras guanosine triphosphate-binding
proteins is generated by a constitutive de/reacylation cycle that operates on palmitoylated
proteins, driving their rapid exchange between the plasma membrane (PM) and the Golgi apparatus.
- id: PMID:18641128
title: Endothelial nitric oxide synthase regulates N-Ras activation on the Golgi
complex of antigen-stimulated T cells.
findings: []
- id: PMID:19946888
title: Defining the membrane proteome of NK cells.
findings: []
- id: PMID:20080631
title: Ras membrane orientation and nanodomain localization generate isoform diversity.
findings: []
- id: PMID:20458337
title: MHC class II-associated proteins in B-cell exosomes and potential functional
implications for exosome biogenesis.
findings: []
- id: PMID:21478863
title: ERK and PDE4 cooperate to induce RAF isoform switching in melanoma.
findings: []
- id: PMID:21968647
title: PAQR10 and PAQR11 mediate Ras signaling in the Golgi apparatus.
findings:
- statement: NRAS localizes to and is activated at the Golgi apparatus; Golgi-resident
PAQR10/PAQR11 bind NRAS and elevate its Golgi localization and activation.
supporting_text: Overexpression of PAQR10/PAQR11 markedly elevates Golgi localization of
HRas, NRas and KRas4A, but not KRas4B.
- id: PMID:23209302
title: KIF14 negatively regulates Rap1a-Radil signaling during breast cancer progression.
findings: []
- id: PMID:23619365
title: MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy.
findings:
- statement: NRAS is a target of miR-146a in endothelial cells; miR-146a downregulates NRAS
and attenuates angiogenesis, implicating NRAS in endothelial cell proliferation.
supporting_text: which attenuated angiogenesis through downregulation of NRAS.
- id: PMID:26701913
title: ABHD17 proteins are novel protein depalmitoylases that regulate N-Ras palmitate
turnover and subcellular localization.
findings:
- statement: ABHD17 depalmitoylase activity controls N-Ras palmitate turnover and
relocalization between plasma membrane and internal membranes.
supporting_text: ABHD17 catalytic activity is required for N-Ras depalmitoylation and
re-localization to internal cellular membranes.
- id: PMID:28514442
title: Architecture of the human interactome defines protein communities and disease
networks.
findings: []
- id: PMID:30194290
title: Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A
as a KRAS-specific vulnerability.
findings: []
- id: PMID:30712867
title: Pharmacological Targeting of STK19 Inhibits Oncogenic NRAS-Driven Melanomagenesis.
findings:
- statement: STK19 phosphorylates NRAS at Ser-89 to enhance binding to downstream effectors,
promoting oncogenic NRAS signaling; provides direct evidence for NRAS GTPase/signal
transduction function.
supporting_text: STK19 phosphorylates NRAS to enhance its binding to its downstream effectors
and promotes oncogenic NRAS-mediated melanocyte malignant transformation.
- statement: Activating NRAS mutations are common in melanoma.
supporting_text: Activating mutations in NRAS account for 20%-30% of melanoma.
- id: PMID:31209342
title: GGTase3 is a newly identified geranylgeranyltransferase targeting a ubiquitin
ligase.
findings: []
- id: PMID:31980649
title: Extensive rewiring of the EGFR network in colorectal cancer cells expressing
transforming levels of KRAS(G13D).
findings: []
- id: PMID:32296183
title: A reference map of the human binary protein interactome.
findings: []
- id: PMID:32707033
title: Kinase Interaction Network Expands Functional and Disease Roles of Human
Kinases.
findings: []
- id: PMID:32814053
title: Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins
and Uncovers Widespread Protein Aggregation in Affected Brains.
findings: []
- id: PMID:33961781
title: Dual proteome-scale networks reveal cell-specific remodeling of the human
interactome.
findings: []
- id: PMID:34591642
title: A protein network map of head and neck cancer reveals PIK3CA mutant drug
sensitivity.
findings: []
- id: PMID:35512704
title: Systematic discovery of mutation-directed neo-protein-protein interactions
in cancer.
findings: []
- id: PMID:35831509
title: Structure-function analysis of the SHOC2-MRAS-PP1C holophosphatase complex.
findings:
- statement: Active GTP-bound NRAS (like other RAS isoforms) can bind SHOC2 and PP1C to form a
holophosphatase complex that promotes RAF activation and positively regulates Ras/MAPK
signaling.
supporting_text: SHOC2 and PP1c preferably bind M-Ras/MRAS, but they also bind K-Ras/KRAS,
N-Ras/NRAS and H-Ras/HRAS
- id: PMID:35839996
title: A Proteomic Approach Identifies Isoform-Specific and Nucleotide-Dependent
RAS Interactions.
findings: []
- id: PMID:40205054
title: Multimodal cell maps as a foundation for structural and functional genomics.
findings: []
- id: Reactome:R-HSA-1168636
title: p-RasGRP1,3:DAG cause RAS to exchange GDP for GTP
findings: []
- id: Reactome:R-HSA-1225951
title: SOS-mediated nucleotide exchange of RAS (mediated by GRB2:SOS1 in complex
with ligand-responsive p-6Y-EGFR mutants)
findings: []
- id: Reactome:R-HSA-1225957
title: SOS-mediated nucleotide exchange of RAS (mediated by GRB2:SOS1 in complex
with phosphorylated SHC1 and ligand-responsive p-6Y-EGFR mutants)
findings: []
- id: Reactome:R-HSA-1250383
title: RAS guanyl-nucleotide exchange mediated by SOS1 in complex with GRB2 and
p-Y349,350-SHC1:p-ERBB4
findings: []
- id: Reactome:R-HSA-1306972
title: RAS guanyl nucleotide exchange mediated by SOS1 bound to GRB2 in complex
with phosphorylated ERBB4:ERBB2 heterodimers
findings: []
- id: Reactome:R-HSA-1433471
title: Activation of RAS by p-KIT bound SOS1
findings: []
- id: Reactome:R-HSA-170986
title: Ral-GDS binds to Ras-GTP
findings: []
- id: Reactome:R-HSA-177938
title: SOS1-mediated nucleotide exchange of RAS (EGF:EGFR:GRB2:SOS1)
findings: []
- id: Reactome:R-HSA-177945
title: SOS1-mediated nucleotide exchange of RAS (EGF:EGFR:SHC1:GRB2:SOS1)
findings: []
- id: Reactome:R-HSA-186834
title: SOS-mediated nucleotide exchange on RAS (PDGF receptor:GRB2:SOS)
findings: []
- id: Reactome:R-HSA-210977
title: Sos-mediated nucleotide exchange of Ras (Tie2 receptor:Grb2:Sos)
findings: []
- id: Reactome:R-HSA-2179407
title: SOS1-mediated nucleotide exchange of RAS (HB-EFG-initiated)
findings: []
- id: Reactome:R-HSA-2424477
title: SOS mediated nucleotide exchange of RAS (SHC)
findings: []
- id: Reactome:R-HSA-392054
title: NCAM1:pFAK:Grb2:Sos-mediated nucleotide exchange of Ras
findings: []
- id: Reactome:R-HSA-5218845
title: p-SPHK1 phosphorylates sphingosine to sphingosine 1-phosphate
findings: []
- id: Reactome:R-HSA-5621573
title: CD209 activate GTPase RAS
findings: []
- id: Reactome:R-HSA-5624486
title: SFKs phosphorylates RAF1 on Y340,Y341
findings: []
- id: Reactome:R-HSA-5624492
title: PAK phosphorylates p21 RAF1 on S338
findings: []
- id: Reactome:R-HSA-5624494
title: RAF1 binds p21 RAS:GTP
findings: []
- id: Reactome:R-HSA-5637806
title: SOS-mediated nucleotide exchange of RAS (mediated by GRB2:SOS1 in complex
with p-EGFRvIII)
findings: []
- id: Reactome:R-HSA-5637808
title: SOS-mediated nucleotide exchange of RAS (mediated by GRB2:SOS1 in complex
with phosphorylated SHC1 and p-EGFRvIII)
findings: []
- id: Reactome:R-HSA-5654392
title: Activated FGFR1:p-FRS:GRB2:SOS1 activates RAS nucleotide exchange
findings: []
- id: Reactome:R-HSA-5654402
title: Activated FGFR2:p-SHC1:GRB2:SOS1 activates RAS nucleotide exchange
findings: []
- id: Reactome:R-HSA-5654413
title: Activated FGFR3:p-FRS2:GRB2:SOS1 activates RAS nucleotide exchange
findings: []
- id: Reactome:R-HSA-5654426
title: Activated FGFR4:p-SHC1:GRB2:SOS1 activates RAS nucleotide exchange
findings: []
- id: Reactome:R-HSA-5654600
title: Activated FGFR1:p-SHC1:GRB2:SOS1 activates RAS nucleotide exchange
findings: []
- id: Reactome:R-HSA-5654618
title: Activated FGFR2:p-FRS2:GRB2:SOS1 activates RAS nucleotide exchange
findings: []
- id: Reactome:R-HSA-5654647
title: Activated FGFR3:p-SHC1:GRB2:SOS1 activates RAS nucleotide exchange
findings: []
- id: Reactome:R-HSA-5654663
title: Activated FGFR4:p-FRS2:GRB2:SOS1 activates RAS nucleotide exchange
findings: []
- id: Reactome:R-HSA-5655241
title: Activated FGFR2 mutants:p-FRS2:GRB2:SOS1 activates RAS nucleotide exchange
findings: []
- id: Reactome:R-HSA-5655277
title: Activated FGFR3 point, translocation and fusion mutants:p-FRS2:GRB2:SOS1
activates RAS nucleotide exchange
findings: []
- id: Reactome:R-HSA-5655326
title: Activated FGFR1 mutants:p-FRS2:GRB2:SOS1 activates RAS nucleotide exchange
findings: []
- id: Reactome:R-HSA-5655347
title: Activated FGFR4 mutants:p-FRS2:GRB2:SOS1 activates RAS nucleotide exchange
findings: []
- id: Reactome:R-HSA-5658231
title: RAS GAPs stimulate RAS GTPase activity
findings: []
- id: Reactome:R-HSA-5658435
title: RAS GAPs bind RAS:GTP
findings: []
- id: Reactome:R-HSA-5672950
title: '"Activator" RAF:YWHAB dimer binds RAS:GTP'
findings: []
- id: Reactome:R-HSA-5672965
title: RAS GEFs promote RAS nucleotide exchange
findings: []
- id: Reactome:R-HSA-5672966
title: RAS:GTP:'activator' RAF homo/heterodimerizes with other RAF monomers
findings: []
- id: Reactome:R-HSA-5672969
title: Phosphorylation of RAF
findings: []
- id: Reactome:R-HSA-5672972
title: MAP2Ks and MAPKs bind to the activated RAF complex
findings: []
- id: Reactome:R-HSA-5672973
title: MAP2Ks phosphorylate MAPKs
findings: []
- id: Reactome:R-HSA-5672978
title: RAF phosphorylates MAP2K dimer
findings: []
- id: Reactome:R-HSA-5672980
title: Dissociation of RAS:RAF complex
findings: []
- id: Reactome:R-HSA-5673001
title: RAF/MAP kinase cascade
findings: []
- id: Reactome:R-HSA-5674018
title: BRAP binds RAS:GTP
findings: []
- id: Reactome:R-HSA-5674022
title: BRAP autoubiquitinates
findings: []
- id: Reactome:R-HSA-5675417
title: PEBP1 binds activated RAF1
findings: []
- id: Reactome:R-HSA-5675431
title: PP2A dephosphorylates RAF1
findings: []
- id: Reactome:R-HSA-5675433
title: PP5 dephosphorylates RAF1 S338
findings: []
- id: Reactome:R-HSA-6798747
title: Exocytosis of tertiary granule membrane proteins
findings: []
- id: Reactome:R-HSA-6802834
title: RAS GTPase mutants don't hydrolyze GTP
findings: []
- id: Reactome:R-HSA-6802837
title: Loss-of-function NF1 variants don't stimulate RAS GTPase activity
findings: []
- id: Reactome:R-HSA-6802908
title: RAS mutants bind inactive RAF
findings: []
- id: Reactome:R-HSA-6802914
title: RAS:GTP:moderate kinase activity p-RAF complexes bind MAP2Ks and MAPKs
findings: []
- id: Reactome:R-HSA-6802915
title: Moderate kinase activity BRAF mutants bind RAS:GTP
findings: []
- id: Reactome:R-HSA-6802916
title: RAF is phosphorylated downstream of moderate kinase activity BRAF mutants
findings: []
- id: Reactome:R-HSA-6802918
title: Activated MAP2Ks phosphorylate MAPKs downstream of inactive BRAF mutants
findings: []
- id: Reactome:R-HSA-6802919
title: RAS:GTP:moderate kinase activity p-RAF complexes phosphorylate MAP2Ks
findings: []
- id: Reactome:R-HSA-6802921
title: Activated MAP2Ks phosphorylate MAPKs downstream of moderate kinase activity
BRAF mutants
findings: []
- id: Reactome:R-HSA-6802922
title: Activated MAP2Ks phosphorylate MAPKs downstream of oncogenic RAS
findings: []
- id: Reactome:R-HSA-6802924
title: RAF is phosphorylated downstream of oncogenic RAS
findings: []
- id: Reactome:R-HSA-6802925
title: Mutant RAS:p-RAF complexes bind MAP2Ks and MAPKs
findings: []
- id: Reactome:R-HSA-6802926
title: Mutant RAS:p-RAF complexes phosphorylate MAP2Ks
findings: []
- id: Reactome:R-HSA-6802937
title: Inactive BRAF mutants bind mutant RAS:GTP
findings: []
- id: Reactome:R-HSA-6802941
title: RAF is paradoxically phosphorylated downstream of kinase-inactive RAF
findings: []
- id: Reactome:R-HSA-6802942
title: RAS:GTP:p-RAF complexes paradoxically bind MAP2Ks and MAPKs
findings: []
- id: Reactome:R-HSA-6802943
title: RAS:GTP:inactive p-RAF complexes phosphorylate MAP2Ks
findings: []
- id: Reactome:R-HSA-6803230
title: Dissociation of moderate activity BRAF complexes
findings: []
- id: Reactome:R-HSA-6803233
title: Dissociation of oncogenic RAS:RAF complex
findings: []
- id: Reactome:R-HSA-6803234
title: Dissociation of paradoxically activated RAS:BRAF complexes
findings: []
- id: Reactome:R-HSA-6803240
title: Homo- or heterodimerization of RAF downstream of mutant RAS
findings: []
- id: Reactome:R-HSA-8851827
title: RAS guanyl nucleotide exchange by MET-bound GRB2:SOS1
findings: []
- id: Reactome:R-HSA-8851877
title: RAS guanyl nucleotide exchange by SOS1 associated with RANBP9 and MET
findings: []
- id: Reactome:R-HSA-8851899
title: RAS guanyl nucleotide exchange by SOS1 bound to GRB2, SCH1-2 and MET
findings: []
- id: Reactome:R-HSA-8936676
title: Moderate kinase activity BRAF mutants:RAS:GTP homo/heterodimerize
findings: []
- id: Reactome:R-HSA-8936731
title: Inactive BRAF mutants:mutant RAS:GTP bind RAF1
findings: []
- id: Reactome:R-HSA-8941613
title: Activated FGFR4:p-FRS:p-PTPN11 activates RAS nucleotide exchange
findings: []
- id: Reactome:R-HSA-8941618
title: Activated FGFR2:p-FRS:p-PTPN11 activates RAS nucleotide exchange
findings: []
- id: Reactome:R-HSA-8941623
title: Activated FGFR1:p-FRS:p-PTPN11 activates RAS nucleotide exchange
findings: []
- id: Reactome:R-HSA-8941628
title: Activated FGFR3:p-FRS:p-PTPN11 activates RAS nucleotide exchange
findings: []
- id: Reactome:R-HSA-8981353
title: RASA1 stimulates RAS GTPase activity
findings: []
- id: Reactome:R-HSA-8981355
title: RASA1 binds RAS:GTP
findings: []
- id: Reactome:R-HSA-9607304
title: SOS1-mediated nucleotide exchange of RAS downstream of FLT3
findings: []
- id: Reactome:R-HSA-9632906
title: PRKCZ recruits RAS in response to estrogen stimulation
findings: []
- id: Reactome:R-HSA-9632918
title: PRKCZ stimulates RAS nucleotide exchange in response to estrogen
findings: []
- id: Reactome:R-HSA-9634418
title: RAS guanyl-nucleotide exchange mediated by SOS1 in complex with GRB2 and
ERBB2 homodimer:p-SHC1
findings: []
- id: Reactome:R-HSA-9647977
title: ICMT methylates S-Farn RAS proteins
findings: []
- id: Reactome:R-HSA-9647978
title: pro-RAS proteins are farnesylated
findings: []
- id: Reactome:R-HSA-9647980
title: mature RAS proteins translocate to plasma membrane
findings: []
- id: Reactome:R-HSA-9647982
title: S-farn Me-HRAS, -NRAS and -KRAS4A are palmitoylated
findings: []
- id: Reactome:R-HSA-9647994
title: RAS proteins are depalmitoylated
findings: []
- id: Reactome:R-HSA-9647999
title: RCE1 cleaves S-Farn proRAS proteins
findings: []
- id: Reactome:R-HSA-9649733
title: mature p21 RAS binds GDP
findings: []
- id: Reactome:R-HSA-9649735
title: Intrinsic nucleotide exchange on RAS
findings: []
- id: Reactome:R-HSA-9649736
title: RAS intrinsic GTPase activity hydrolyzes GTP to GDP
findings: []
- id: Reactome:R-HSA-9651280
title: RAS GAP mutants aren't stimulated by GAPs
findings: []
- id: Reactome:R-HSA-9653108
title: Raf dimer inhibitors bind RAF heterodimers
findings: []
- id: Reactome:R-HSA-9656209
title: Dissociation of RAS:RAF1 mutant complex
findings: []
- id: Reactome:R-HSA-9656211
title: MAP2Ks and MAPKs bind to the activated mutant RAF1 complex
findings: []
- id: Reactome:R-HSA-9656212
title: Phosphorylation of RAF1 mutants
findings: []
- id: Reactome:R-HSA-9656213
title: RAF1 mutants show enhanced heterodimerization with BRAF
findings: []
- id: Reactome:R-HSA-9656214
title: MAP2Ks phosphorylate MAPKs downstream of RAF1 mutants
findings: []
- id: Reactome:R-HSA-9656215
title: RAF1 mutant complexes phosphorylate MAP2K dimer
findings: []
- id: Reactome:R-HSA-9657599
title: Dual mechanism MAP2K inhibitors bind MAP2Ks
findings: []
- id: Reactome:R-HSA-9657603
title: Dual mechanism MAPK inhibitors bind MAPKs
findings: []
- id: Reactome:R-HSA-9657606
title: Single mechanism MAP2K inhibitors bind phosphorylated MAP2Ks
findings: []
- id: Reactome:R-HSA-9657608
title: Single mechanism MAPK inhibitors bind phosphorylated MAPK
findings: []
- id: Reactome:R-HSA-9658253
title: RAS:GTP binds PI3K
findings: []
- id: Reactome:R-HSA-9664991
title: RAS activation by SOS1 bound to phosphorylated heterodimers of ERBB2 KD mutants
findings: []
- id: Reactome:R-HSA-9665009
title: RAS activation by SOS1 bound to phosphorylated heterodimers of ERBB2 KD mutants
and EGFR
findings: []
- id: Reactome:R-HSA-9665404
title: RAS guanyl nucleotide exchange mediated by the p-6Y- ERBB2 ECD mutants:EGF:p-6Y-EGFR:p-SHC1:GRB2:SOS1
findings: []
- id: Reactome:R-HSA-9665408
title: RAS activation by SOS1 bound to phosphorylated heterodimers of ERBB2 ECD
mutants and EGFR through GRB2
findings: []
- id: Reactome:R-HSA-9665700
title: RAS activation by SOS1 bound to phosphorylated heterodimers of ERBB2 TMD/JMD
mutants
findings: []
- id: Reactome:R-HSA-9665707
title: RAS activation by SOS1 bound to phosphorylated heterodimers of ERBB2 TMD/JMD
mutants and EGFR
findings: []
- id: Reactome:R-HSA-9670436
title: p-KIT mutants:GRB2:SOS catalyzes nucleotide exchange on RAS
findings: []
- id: Reactome:R-HSA-9672163
title: SOS-mediated nucleotide exchange on RAS downstream of PDGFRA extracellular
domain dimers
findings: []
- id: Reactome:R-HSA-9672170
title: SOS-mediated nucleotide exchange of RAS downstream of mutant PDGFR receptors
findings: []
- id: Reactome:R-HSA-9695853
title: FLT3 mutants:GRB2:SOS1-mediated nucleotide exchange on RAS
findings: []
- id: Reactome:R-HSA-9703441
title: SOS1-mediated nucleotide exchange of RAS downstream of FLT3 fusion mutants
findings: []
- id: file:human/NRAS/NRAS-uniprot.txt
title: UniProtKB P01111 (RASN_HUMAN) GTPase NRas record
findings:
- statement: NRAS binds GDP/GTP and possesses intrinsic GTPase activity (EC 3.6.5.2), cycling
between GDP-bound inactive and GTP-bound active states under GEF/GAP control.
supporting_text: Ras proteins bind GDP/GTP and possess intrinsic GTPase activity.
- statement: NRAS is a lipid-anchored peripheral membrane protein on the cytoplasmic side of
the cell membrane and Golgi apparatus membrane, shuttling between the two.
supporting_text: 'Note=Shuttles between the plasma membrane and the Golgi apparatus.'
- statement: NRAS is farnesylated at Cys-186 and palmitoylated at Cys-181; palmitoylation by
ZDHHC9-GOLGA7 and depalmitoylation by ABHD17A/B/C regulate PM-Golgi exchange.
supporting_text: A continuous cycle of de- and re-palmitoylation regulates rapid exchange
between plasma membrane and Golgi
- statement: Oncogenic codon 12/13/61 mutations impair GTP hydrolysis and lock NRAS in the
active GTP-bound state, transforming cells.
supporting_text: Mutations which change AA 12, 13 or 61 activate the potential of Ras to
transform cultured cells and are implicated in a variety of human tumors.
core_functions:
- description: NRAS is a membrane-anchored small GTPase that acts as a binary molecular switch,
binding GDP/GTP and hydrolyzing GTP to GDP via its intrinsic GTPase activity.
molecular_function:
id: GO:0003924
label: GTPase activity
supported_by:
- reference_id: file:human/NRAS/NRAS-uniprot.txt
supporting_text: Ras proteins bind GDP/GTP and possess intrinsic GTPase activity.
- reference_id: PMID:30712867
supporting_text: STK19 phosphorylates NRAS to enhance its binding to its downstream effectors
and promotes oncogenic NRAS-mediated melanocyte malignant transformation.
- description: Active GTP-bound NRAS at the plasma membrane transduces receptor tyrosine kinase
signals to downstream effectors, activating the RAF-MEK-ERK MAPK cascade.
molecular_function:
id: GO:0003924
label: GTPase activity
directly_involved_in:
- id: GO:0007265
label: Ras protein signal transduction
- id: GO:0000165
label: MAPK cascade
locations:
- id: GO:0005886
label: plasma membrane
- id: GO:0000139
label: Golgi membrane
supported_by:
- reference_id: PMID:30712867
supporting_text: STK19 phosphorylates NRAS to enhance its binding to its downstream effectors
and promotes oncogenic NRAS-mediated melanocyte malignant transformation.
- reference_id: PMID:18641128
supporting_text: eNOS selectively activates N-Ras but not K-Ras on the Golgi complex of T
cells engaged with APC.
- description: NRAS undergoes a de/re-palmitoylation acylation cycle that drives its shuttling
between the plasma membrane and the Golgi apparatus, providing spatial control of signaling.
locations:
- id: GO:0005886
label: plasma membrane
- id: GO:0000139
label: Golgi membrane
supported_by:
- reference_id: PMID:15705808
supporting_text: driving their rapid exchange between the plasma membrane (PM) and the Golgi
apparatus.
- reference_id: PMID:26701913
supporting_text: ABHD17 catalytic activity is required for N-Ras depalmitoylation and
re-localization to internal cellular membranes.
proposed_new_terms: []
suggested_questions:
- question: To what extent are NRAS-specific (versus pan-RAS) downstream signaling outputs and
effector preferences attributable to its hypervariable region and its distinctive
palmitoylation/depalmitoylation-driven PM-Golgi trafficking?
experts:
- McCormick F
- Bastiaens PIH
- question: Should NRAS receive a distinct molecular-function annotation for RAF/effector binding
(e.g., a Ras-effector engagement term) given the many curated effector interactions currently
captured only as generic protein binding?
experts:
- Thomas GV
suggested_experiments:
- hypothesis: NRAS effector engagement and signaling output are quantitatively shaped by its
palmitoylation-dependent localization between plasma membrane and Golgi.
description: Use acylation-cycle mutants (e.g., Cys181Ser) and ABHD17/ZDHHC9 perturbations
combined with FRET-based Ras activity biosensors and phospho-ERK readouts to map how
subcellular localization governs NRAS-driven MAPK activation.
experiment_type: live-cell signaling and localization assay
- hypothesis: Ser-89 phosphorylation by STK19 selectively enhances oncogenic NRAS effector
binding and MAPK output.
description: Compare effector co-immunoprecipitation, GTP-loading, and downstream ERK
activation for wild-type, S89A, and oncogenic (Q61R) NRAS in STK19-proficient versus
STK19-deficient cells.
experiment_type: biochemical effector-binding and phosphorylation assay